Works matching DE "CYTOPENIA"

Results: 118
    1
    2
    3
    4
    5
    6

    Real-World Evidence on Adverse Events and Healthcare Resource Utilization in Patients with Chronic Lymphocytic Leukaemia in Spain Using Natural Language Processing: The SRealCLL Study.

    Published in:
    Cancers, 2024, v. 16, n. 23, p. 4004, doi. 10.3390/cancers16234004
    By:
    • Abrisqueta-Costa, Pau;
    • García-Marco, José Antonio;
    • Gutiérrez, Antonio;
    • Hernández-Rivas, José Ángel;
    • Andreu-Lapiedra, Rafael;
    • Arguello-Tomas, Miguel;
    • Leiva-Farré, Carolina;
    • López-Roda, María Dolores;
    • Callejo-Mellén, Ángel;
    • Álvarez-García, Esther;
    • Loscertales, Javier
    Publication type:
    Article
    7

    Comparing R-Bendamustine vs. R-CHOP Plus Maintenance Therapy as First-Line Systemic Treatment in Follicular Lymphoma: A Multicenter Retrospective GELTAMO Study.

    Published in:
    Cancers, 2024, v. 16, n. 7, p. 1285, doi. 10.3390/cancers16071285
    By:
    • Bastos-Oreiro, Mariana;
    • Gutierrez, Antonio;
    • Cabero, Almudena;
    • López, Javier;
    • Villafuerte, Paola;
    • Jiménez-Ubieto, Ana;
    • de Oña, Raquel;
    • De la Fuente, Adolfo;
    • Navarro, Belén;
    • Peñalver, Javier;
    • Martínez, Pilar;
    • Alonso, Carmen;
    • Infante, María;
    • Córdoba, Raúl;
    • Perez-Montero, Blanca;
    • Pérez de Oteyza, Jaime;
    • González de Villambrosio, Sonia;
    • Fernández-Caldas, Paula;
    • del Campo, Raquel;
    • García Belmonte, Daniel
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 4, p. 1109, doi. 10.1111/bjh.20018
    By:
    • Kusne, Yael;
    • Badar, Talha;
    • Lasho, Terra;
    • Marando, Ludovica;
    • Mangaonkar, Abhishek A.;
    • Finke, Christy;
    • Foran, James M.;
    • Al‐Kali, Aref;
    • Palmer, Jeanne;
    • Arana Yi, Cecilia;
    • Alkhateeb, Hassan B.;
    • Gangat, Naseema;
    • Viswanatha, David;
    • Litzow, Mark R.;
    • Chlon, Timothy;
    • Ferrer, Alejandro;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    37

    JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 2, p. 758, doi. 10.1111/bjh.19979
    By:
    • Ceccardi, Andrea;
    • Dameri, Martina;
    • Ravera, Francesco;
    • Gilardi, Nicolò;
    • Stabile, Mario;
    • Lombardo, Isabella;
    • Ceresa, Davide;
    • Colombo, Monica;
    • Vigo, Tiziana;
    • Cigolini, Benedetta;
    • Rivoli, Giulia;
    • Dragani, Matteo;
    • Solimano, Irene;
    • Garuti, Anna;
    • Bellodi, Andrea;
    • Ballestrero, Alberto;
    • Ferrando, Lorenzo;
    • Zoppoli, Gabriele
    Publication type:
    Article
    38

    Secondary haematological dysplasia after CAR‐T‐cell therapy for acute lymphoblastic leukaemia in children.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 1, p. 186, doi. 10.1111/bjh.19862
    By:
    • Theron, Alexandre;
    • Alonso‐Saladrigues, Anna;
    • Dapena, Jose‐Luis;
    • López‐Duarte, Mónica;
    • Diaz de Heredia, Cristina;
    • Verdú‐Amorós, Jaime;
    • Sarrate, Edurne;
    • Esperanza‐Cebollada, Elena;
    • Cuatrecasas, Esther;
    • Andreu, Sandra;
    • Conde, Nuria;
    • Sanchez‐Sierra, Nazaret;
    • Isola, Ignacio;
    • Camós, Mireia;
    • Torrebadell, Montse;
    • Rives, Susana;
    • Català, Albert
    Publication type:
    Article
    39
    40

    Association of paediatric autoimmune cytopenia and inflammatory bowel disease suggests a common genetic origin.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 4, p. 1508, doi. 10.1111/bjh.19701
    By:
    • Gilton, M.;
    • Fernandes, H.;
    • Martinez, C.;
    • Leverger, G.;
    • Abou Chahla, W.;
    • Li Thiao Te, V.;
    • Deparis, M.;
    • Armari Alla, C.;
    • Garnier, N.;
    • Benadiba, J.;
    • Marie‐Cardine, A.;
    • Rieux‐Laucat, F.;
    • Picard, C.;
    • Aladjidi, N.;
    • Leblanc, T.;
    • Heritier, Sébastien;
    • Fahd, Mony;
    • Pasquet, Marlène;
    • Thomas, Caroline;
    • Barlogis, Vincent
    Publication type:
    Article
    41
    42

    Changes in T‐cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T‐cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 3, p. 999, doi. 10.1111/bjh.19515
    By:
    • Zhou, Xiang;
    • Wagner, Vivien;
    • Scheller, Lukas;
    • Stanojkovska, Emilia;
    • Riedhammer, Christine;
    • Xiao, Xianghui;
    • Steinhardt, Maximilian Johannes;
    • Vogt, Cornelia;
    • Nerreter, Silvia;
    • Eisele, Florian;
    • John, Mara;
    • Munawar, Umair;
    • Kadel, Sofie‐Katrin;
    • Mersi, Julia;
    • Ruckdeschel, Anna;
    • Schimanski, Sven;
    • Haertle, Larissa;
    • Waldschmidt, Johannes Moritz;
    • Han, Seungbin;
    • Topp, Max
    Publication type:
    Article
    43
    44

    Autoimmune cytopenia and Kabuki syndrome in paediatrics: Insights in 11 patients.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 5, p. 1899, doi. 10.1111/bjh.19387
    By:
    • Bianchi, Chloé;
    • Margot, Henri;
    • Fernandes, Helder;
    • Pasquet, Marlène;
    • Priqueler, Laurence;
    • Roy‐Peaud, Frédérique;
    • Bauduer, Frédéric;
    • Bayart, Sophie;
    • Garnier, Nathalie;
    • Fain, Olivier;
    • Van Gils, Julien;
    • Joly, Sandrine Baron;
    • Rialland, Fanny;
    • Paillard, Catherine;
    • Deparis, Marianna;
    • Lambilliotte, Anne;
    • Leblanc, Thierry;
    • Fahd, Mony;
    • Leverger, Guy;
    • Héritier, Sébastien
    Publication type:
    Article
    45

    Efficacy and safety of idecabtagene vicleucel in patients with relapsed–refractory multiple myeloma not meeting the KarMMa‐1 trial eligibility criteria: A real‐world multicentre study.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1293, doi. 10.1111/bjh.19302
    By:
    • Dima, Danai;
    • Rashid, Aliya;
    • Davis, James A.;
    • Shune, Leyla;
    • Abdallah, Al‐Ola;
    • Li, Hong;
    • DeJarnette, Shaun;
    • Khouri, Jack;
    • Williams, Louis;
    • Hashmi, Hamza;
    • Raza, Shahzad;
    • McGuirk, Joseph;
    • Anwer, Faiz;
    • Ahmed, Nausheen
    Publication type:
    Article
    46
    47
    48

    Myelodysplasia Cutis.

    Published in:
    Archives of Pathology & Laboratory Medicine, 2024, v. 148, n. 4, p. 385, doi. 10.5858/arpa.2023-0132-RA
    By:
    • Whittington, Carli P.;
    • Ross, Charles W.;
    • Ramirez, James A.;
    • Lowe, Lori;
    • Brown, Noah;
    • Hristov, Alexandra C.
    Publication type:
    Article
    49
    50